JAMES R O'DELL

Summary

Affiliation: University of Nebraska Medical Center
Country: USA

Publications

  1. doi request reprint Validation of the methotrexate-first strategy in patients with early, poor-prognosis rheumatoid arthritis: results from a two-year randomized, double-blind trial
    JAMES R O'DELL
    University of Nebraska and Omaha VA Medical Center, Omaha, NE 68198 3025, USA
    Arthritis Rheum 65:1985-94. 2013
  2. ncbi request reprint Combinations of conventional disease-modifying antirheumatic drugs
    J R O'Dell
    Section of Rheumatology and Immunology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA
    Rheum Dis Clin North Am 27:415-26, x. 2001
  3. ncbi request reprint Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine
    J R O'Dell
    University of Nebraska Medical Center, Omaha 68198 3025, USA
    Arthritis Rheum 44:2235-41. 2001
  4. ncbi request reprint Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial
    JAMES R O'DELL
    University of Nebraska Medical Center, Omaha 68198, USA
    Arthritis Rheum 46:1164-70. 2002
  5. ncbi request reprint Rheumatoid arthritis initial therapy: unanswered questions
    James O'Dell
    Department of Internal Medicine, University of Nebraska, Omaha, NE 68198 3025, USA
    J Rheumatol Suppl 72:14-6. 2005
  6. ncbi request reprint Etanercept in combination with sulfasalazine, hydroxychloroquine, or gold in the treatment of rheumatoid arthritis
    JAMES R O'DELL
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha, 983025, USA
    J Rheumatol 33:213-8. 2006
  7. doi request reprint Pharmacotherapy: concepts of pathogenesis and emerging treatments. Challenges in clinical trial design in inflammatory arthritis
    JAMES R O'DELL
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska 68198 3025, USA
    Best Pract Res Clin Rheumatol 24:457-61. 2010
  8. pmc Serum cotinine as a biomarker of tobacco exposure and the association with treatment response in early rheumatoid arthritis
    Leann B Maska
    University of Nebraska Medical Center, Omaha, NE 68198 3025, USA
    Arthritis Care Res (Hoboken) 64:1804-10. 2012
  9. ncbi request reprint Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone
    JAMES R O'DELL
    University of Nebraska Medical Center, Omaha, USA
    Arthritis Rheum 54:621-7. 2006
  10. doi request reprint Therapies for active rheumatoid arthritis after methotrexate failure
    JAMES R O'DELL
    Veterans Affairs VA Nebraska Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE 68105, USA
    N Engl J Med 369:307-18. 2013

Collaborators

Detail Information

Publications23

  1. doi request reprint Validation of the methotrexate-first strategy in patients with early, poor-prognosis rheumatoid arthritis: results from a two-year randomized, double-blind trial
    JAMES R O'DELL
    University of Nebraska and Omaha VA Medical Center, Omaha, NE 68198 3025, USA
    Arthritis Rheum 65:1985-94. 2013
    ..The purpose of this study was to examine outcomes of a blinded trial of initial MTX monotherapy with the option to step-up to combination therapy as compared to immediate combination therapy in patients with early, poor-prognosis RA...
  2. ncbi request reprint Combinations of conventional disease-modifying antirheumatic drugs
    J R O'Dell
    Section of Rheumatology and Immunology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA
    Rheum Dis Clin North Am 27:415-26, x. 2001
    ..Importantly, controlled studies have now shown many combinations to be well tolerated and significantly more effective than mono-DMARD therapy...
  3. ncbi request reprint Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine
    J R O'Dell
    University of Nebraska Medical Center, Omaha 68198 3025, USA
    Arthritis Rheum 44:2235-41. 2001
    ..To compare the efficacy of minocycline with that of a conventional disease-modifying antirheumatic drug (DMARD), hydroxychloroquine, in patients with early seropositive rheumatoid arthritis (RA)...
  4. ncbi request reprint Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial
    JAMES R O'DELL
    University of Nebraska Medical Center, Omaha 68198, USA
    Arthritis Rheum 46:1164-70. 2002
    ..To compare the efficacy of combination therapy with methotrexate (MTX) and hydroxychloroquine (HCQ), MTX and sulfasalazine (SSZ), and MTX, HCQ, and SSZ in patients with rheumatoid arthritis (RA)...
  5. ncbi request reprint Rheumatoid arthritis initial therapy: unanswered questions
    James O'Dell
    Department of Internal Medicine, University of Nebraska, Omaha, NE 68198 3025, USA
    J Rheumatol Suppl 72:14-6. 2005
    ....
  6. ncbi request reprint Etanercept in combination with sulfasalazine, hydroxychloroquine, or gold in the treatment of rheumatoid arthritis
    JAMES R O'DELL
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha, 983025, USA
    J Rheumatol 33:213-8. 2006
    ..To prospectively determine the efficacy and safety of etanercept in combination with sulfasalazine (SSZ), hydroxychloroquine (HCQ), and gold in the treatment of rheumatoid arthritis (RA)...
  7. doi request reprint Pharmacotherapy: concepts of pathogenesis and emerging treatments. Challenges in clinical trial design in inflammatory arthritis
    JAMES R O'DELL
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska 68198 3025, USA
    Best Pract Res Clin Rheumatol 24:457-61. 2010
    ..Essentially, rheumatologists now have many more therapeutic options than they know what to do with. This article discusses why we are in this situation and suggests opportunities to move forward...
  8. pmc Serum cotinine as a biomarker of tobacco exposure and the association with treatment response in early rheumatoid arthritis
    Leann B Maska
    University of Nebraska Medical Center, Omaha, NE 68198 3025, USA
    Arthritis Care Res (Hoboken) 64:1804-10. 2012
    ..Knowledge of whether tobacco exposure reduces treatment efficacy is important, since smoking could represent a modifiable factor in optimizing RA treatment...
  9. ncbi request reprint Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone
    JAMES R O'DELL
    University of Nebraska Medical Center, Omaha, USA
    Arthritis Rheum 54:621-7. 2006
    ....
  10. doi request reprint Therapies for active rheumatoid arthritis after methotrexate failure
    JAMES R O'DELL
    Veterans Affairs VA Nebraska Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE 68105, USA
    N Engl J Med 369:307-18. 2013
    ....
  11. doi request reprint Therapeutic options for rheumatoid arthritis
    Michael G Feely
    University of Nebraska Medical Center, Section of Rheumatology and Immunology, Department of Internal Medicine, 983025 Nebraska Medical Center, Omaha, NE 68198 3025, USA
    Expert Opin Pharmacother 10:2095-106. 2009
    ..Recent advances in the understanding of the pathogenesis of RA and the capability of biologically engineered treatments for RA have expanded the armamentarium of antirheumatic agents...
  12. doi request reprint Minocycline-induced hyperpigmentation in rheumatoid arthritis
    Brian T Fay
    Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198 2055, USA
    J Clin Rheumatol 14:17-20. 2008
    ..Minocycline is recognized as an effective, well-tolerated therapy in rheumatoid arthritis (RA), although its use has been associated with the development of cutaneous hyperpigmentation...
  13. pmc Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis
    Ted R Mikuls
    Department of Medicine, Nebraska Arthritis Outcomes Research Center NAORC, University of Nebraska Medical Center and Omaha Veterans Affairs Medical Center, Omaha, NE, USA
    Int Immunopharmacol 9:38-42. 2009
    ..Antibody titers to P. gingivalis are increased in patients with rheumatoid arthritis and are associated with disease-specific autoimmunity...
  14. pmc Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice
    Jaclyn Anderson
    University of Nebraska Medical Center, Omaha, NE, USA
    Arthritis Care Res (Hoboken) 64:640-7. 2012
    ....
  15. doi request reprint Initial management of rheumatoid arthritis
    Anna Gramling
    Division of Rheumatology and Immunology, University of Nebraska Medical Center, 983025 Nebraska Medical Center, Omaha, NE 68198 3025, USA
    Rheum Dis Clin North Am 38:311-25. 2012
    ..This article discusses the initial therapy in early RA and reviews the studies and trials available in the literature...
  16. pmc Anticitrullinated protein antibody (ACPA) in rheumatoid arthritis: influence of an interaction between HLA-DRB1 shared epitope and a deletion polymorphism in glutathione S-transferase in a cross-sectional study
    Ted R Mikuls
    Omaha Veterans Affairs Medical Center and Nebraska Arthritis Outcomes Research Center, University of Nebraska Medical Center, 986270 Nebraska Medical Center, Omaha, NE 68198 6270, USA
    Arthritis Res Ther 12:R213. 2010
    ..The purpose of this study was to examine the associations of GSTM1-null with ACPA positivity in RA and to assess for evidence of interaction between GSTM1 and HLA-DRB1 shared epitope (SE)...
  17. doi request reprint Update on the use of conventional disease-modifying antirheumatic drugs in the management of rheumatoid arthritis
    Michael G Feely
    Department of Internal Medicine, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, 68198 3025, USA
    Curr Opin Rheumatol 22:316-20. 2010
    ..The present review will focus on the role of conventional disease-modifying antirheumatic drugs (DMARDs) in the current management of rheumatoid arthritis (RA)...
  18. doi request reprint Citrullinated mouse collagen administered to DBA/1J mice in the absence of adjuvant initiates arthritis
    Geoffrey M Thiele
    Experimental Immunology Laboratory, Omaha Veterans Administration Medical Center, NE 68105, USA
    Int Immunopharmacol 13:424-31. 2012
    ..However, to date no studies have been performed to determine if these phenotypes can be induced in the absence of an adjuvant...
  19. pmc Anti-CCP antibody and rheumatoid factor concentrations predict greater disease activity in men with rheumatoid arthritis
    Benjamin J Miriovsky
    Department of Internal Medicine, Section of Rheumatology and Immunology, 986270 Nebraska Medical Center, Omaha, NE 68198 6270, USA
    Ann Rheum Dis 69:1292-7. 2010
    ..To examine associations of anti-cyclic citrullinated peptide (aCCP) antibody and rheumatoid factor (RF) concentrations with future disease activity in men with rheumatoid arthritis (RA)...
  20. doi request reprint Induction of bone loss in DBA/1J mice immunized with citrullinated autologous mouse type II collagen in the absence of adjuvant
    Anand Dusad
    Experimental Immunology Laboratory, Omaha Veterans Administration Medical Center, Omaha, NE, 68105, USA
    Immunol Res 58:51-60. 2014
    ..Significant inverse correlations of circulating ACPA and bone quality/quantity were present. ACPA levels predict the adverse bone morphological changes in this model of early RA...
  21. ncbi request reprint Early rheumatoid arthritis: pitfalls in diagnosis and review of recent clinical trials
    Amy C Cannella
    University of Nebraska Medical Center, Omaha, Nebraska 68198 3025, USA
    Drugs 66:1319-37. 2006
    ..However, further research is needed to determine which regimen is appropriate for the individual patient with RA...
  22. ncbi request reprint Prospective study of survival outcomes in Non-Hodgkin's lymphoma patients with rheumatoid arthritis
    Ted R Mikuls
    Department of Medicine, University of Nebraska Medical Center, Omaha, NE 68198 3025, USA
    J Clin Oncol 24:1597-602. 2006
    ..In this prospective study, we examined the association of RA with survival in patients with NHL...
  23. pmc Shoulder arthroplasties have fewer complications than hip or knee arthroplasties in US veterans
    Edward V Fehringer
    Nebraska Arthritis Outcomes Research Center NAORC, Omaha, NE, USA
    Clin Orthop Relat Res 468:717-22. 2010
    ..In a VA population, TSAs required more operative time but resulted in shorter stays, fewer complications, and fewer readmissions than THAs and TKAs...

Research Grants3

  1. Rheumatoid Arthritis: Predictors of Therapeutic Response
    JAMES O DELL; Fiscal Year: 2000
    ..Retrospective analysis of this information can be utilized to plan prospective clinical trials using potentially predictive patterns of cytokine, matrix metalloproteinases, and genetic factors. ..
  2. Rheumatoid Arthritis: Predictors of Therapeutic Response
    JAMES O DELL; Fiscal Year: 2001
    ..Retrospective analysis of this information can be utilized to plan prospective clinical trials using potentially predictive patterns of cytokine, matrix metalloproteinases, and genetic factors. ..
  3. Rheumatoid Arthritis: Predictors of Therapeutic Response
    JAMES O DELL; Fiscal Year: 2002
    ..Retrospective analysis of this information can be utilized to plan prospective clinical trials using potentially predictive patterns of cytokine, matrix metalloproteinases, and genetic factors. ..